Con Panousis Selected Research

Cytokines

1/2018	rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.
1/2016	CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.
5/2014	Identification of potent antagonist antibodies against mouse IL-13Rα1 using novel bioassays.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Con Panousis Research Topics

Disease

3	Thrombosis (Thrombus) 11/2021 - 02/2014
3	Inflammation (Inflammations) 01/2020 - 01/2016
2	Idiopathic Pulmonary Fibrosis 01/2022 - 05/2014
2	Neoplasms (Cancer) 01/2020 - 08/2003
2	Arthritis (Polyarthritis) 01/2018 - 12/2016
2	Asthma (Bronchial Asthma) 01/2016 - 05/2014
2	Hemorrhage 01/2016 - 02/2014
1	Hereditary Angioedemas 01/2023
1	Pulmonary Embolism 01/2023
1	Pathologic Constriction (Stenosis) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Atherosclerosis 01/2022
1	Hemophilia A (Haemophilia) 11/2021
1	Glomerulonephritis 01/2021
1	Aneurysm (Aneurysms) 01/2020
1	Rupture 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Lung Injury 01/2017
1	Infections 12/2016
1	Human Influenza (Influenza) 12/2016
1	Joint Diseases (Joint Disease) 12/2016
1	Rheumatoid Arthritis 12/2016
1	Neuroinflammatory Diseases 01/2016
1	Brain Ischemia (Cerebral Ischemia) 01/2016
1	Reperfusion Injury 01/2016
1	Stroke (Strokes) 01/2016
1	Hereditary Angioedema Type III 08/2015
1	Edema (Dropsy) 08/2015
1	Wounds and Injuries (Trauma) 02/2014
1	Carcinoma (Carcinomatosis) 08/2003

Drug/Important Bio-Agent (IBA)

7	Factor XII (Hageman Factor)IBA 01/2023 - 02/2014
3	Factor XIIa (Coagulation Factor XIIa)IBA 01/2022 - 01/2016
3	CytokinesIBA 01/2018 - 05/2014
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2018
2	Neutralizing AntibodiesIBA 08/2015 - 02/2014
2	Peptide Hydrolases (Proteases)FDA Link 08/2015 - 02/2014
1	Thromboplastin (Tissue Factor)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Factor VIII (Coagulation Factor VIII)IBA 11/2021
1	AlbuminsIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	von Willebrand FactorIBA 11/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	Kallikreins (Kallikrein)IBA 01/2020
1	KininsIBA 01/2020
1	ADAM17 ProteinIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2018
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017
1	Histones (Histone)IBA 01/2017
1	CollagenIBA 12/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2016
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 12/2016
1	SteroidsIBA 01/2016
1	BradykininIBA 08/2015
1	Interleukin-13IBA 05/2014
1	Hemostatics (Antihemorrhagics)IBA 02/2014
1	AnticoagulantsIBA 02/2014
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	FibrinIBA 02/2014
1	A-factor (Streptomyces)IBA 02/2014
1	monoclonal antibody 806IBA 08/2003
1	ErbB Receptors (EGF Receptor)IBA 08/2003
1	AntigensIBA 08/2003
1	epidermal growth factor receptor VIIIIBA 08/2003
1	Hu3S193 monoclonal antibodyIBA 08/2003

Therapy/Procedure

3	Therapeutics 12/2016 - 08/2003
1	Extracorporeal Membrane Oxygenation 01/2016
1	Extracorporeal Circulation 02/2014